Market News / Story
iBio, Inc. Stock 12‑Month Price Target Raised to $5.6, Implies 509% Upside
·
According to estimates from 7 analysts, iBio, Inc. stock's average price target has risen from $5.53 to $5.6, with forecasts ranging from $4.2 to $7 per share Based on the Oct. 8 closing price, the updated target implies approximately 509% potential upside Consensus rating remains at “Buy” across 7 covering analysts, with 7 Buys, 0 Holds and 0 Sells Explore more price target data and ratings for iBio, Inc. on the Forecasts tab , and track all previous and future analyst…